Skip to search.
 TSX Up 0.93% TSX Ventures Up 0.18%

Rigel Pharmaceuticals, Inc. (RIGL)

-NasdaqGS
2.56 Up 0.05(1.99%) 2:51PM EDT - Nasdaq Real Time Price
Prev Close:2.51
Open:2.51
Bid:2.55 x 1200
Ask:2.56 x 1300
1y Target Est:6.50
Beta:1.35055
Earnings Date:Aug 2 - Aug 8 (Est.)
Day's Range:2.43 - 2.58
52wk Range:1.88 - 3.78
Volume:187,903
Avg Vol (3m):426,760
Market Cap:235.89M
P/E (ttm):N/A
EPS (ttm):-0.57
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
RIGLUp 1.99%235.89M
AMGNUp 1.45%116.38B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):7.29
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.45
Quarterly EPS Est (Jun-16) :-0.18
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Rigel Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel and targeted drug candidates in the therapeutic areas of immunology, oncology, and immuno-oncology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback